We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03588650
Brief Title: A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors (HLX20)

First Submitted : June 22, 2018
First Submitted that Met QC Criteria : July 4, 2018
First Posted : July 17, 2018

Last Update Submitted that Met QC Criteria : June 1, 2022
Last Update Posted : June 3, 2022